WHO’s vaccination work represents one of the clearest examples of sustained, science‑based global cooperation in public health, and the attached summary illustrates how far‑reaching and internally coherent this effort...
Download Infographic Overview Historical background: Combination vaccines have been used since 1945, beginning with the trivalent influenza vaccine. Vaccine composition: They combine either different serotypes of one...
In short: Classic vaccines have picked most of the low-hanging fruit: stable-antigen pathogens tamed by robust neutralizing antibodies, leaving the real fun to TB, HIV and other shape-shifters that demand sophisticated...
Europe On 11 December 2025, EMA’s CHMP recommended granting marketing authorisation in the EU for mNexspike, an mRNA COVID-19 vaccine targeting the LP.8.1 variant for the 2025–26 season, adding another option to the...
There are moments when recognition feels less like an achievement and more like a quiet affirmation – a reminder of why the journey began, and why it continues. For me, health literacy has always been deeply...
We are aware of two vaccines in late clinical development (Phase 2 completed) globally to address a significant medical need for pregnant women and their offspring, one from Pfizer in the United States and one from...
In the wake of the COVID19 pandemic and the evolution of mRNA vaccines, the global vaccine industry in 2025 is characterized by rapid expansion of manufacturing capacity, especially for mRNA and other novel platforms...